Cost Effectiveness Analysis of Azithromycin and Doxycycline for Chlamydia Trachomatis Infection in Women: A Canadian Perspective
OBJECTIVE: To assess the cost effectiveness of azithromycin versus doxycycline therapy for cervical Chlamydia trachomatis infections in Canada.
Saved in:
Main Authors: | Fawziah Marra, Carlo A Marra, David M Patrick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1997-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1997/870203 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The laboratory diagnosis of Chlamydia trachomatis infections
by: Max A Chernesky
Published: (2005-01-01) -
In Vitro Activities of Sparfloxacin, Ceftriaxone, Penicillin, Tetracycline and Doxycycline against Chlamydia trachomatis and Neisseria gonhorrhoeae
by: Hazel Talbot, et al.
Published: (1992-01-01) -
Biofilm in Genital Ecosystem: A Potential Risk Factor for Chlamydia trachomatis Infection
by: Simone Filardo, et al.
Published: (2019-01-01) -
Flavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
by: Abebayehu N. Yilma, et al.
Published: (2013-01-01) -
Chlamydia trachomatis Mimicking COVID-19 Chronic Follicular Conjunctivitis
by: Sukhmandeep Kaur, et al.
Published: (2021-01-01)